Immediate Impact
50 standout
Citing Papers
Lorlatinib Versus Crizotinib in Patients With Advanced ALK -Positive Non–Small Cell Lung Cancer: 5-Year Outcomes From the Phase III CROWN Study
2024 Standout
An Update on the Nitrogen Heterocycle Compositions and Properties of U.S. FDA-Approved Pharmaceuticals (2013–2023)
2024 Standout
Works of Adam Roughley being referenced
Reasons for nonuse of antiviral treatment in patients with chronic hepatitis C infection and thrombocytopaenia: a retrospective chart review from five E uropean countries
2014
Impact of Brain Metastases on Quality of Life and Estimated Life Expectancy in Patients with Advanced Non-Small Cell Lung Cancer
2014
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Adam Roughley | 230 | 269 | 51 | 88 | 15 | 541 | |
| Tania Lobo | 138 | 249 | 27 | 87 | 20 | 483 | |
| John P. Enterline | 153 | 204 | 25 | 133 | 24 | 630 | |
| Efstathios Zikos | 171 | 369 | 45 | 96 | 16 | 599 | |
| Jette Vibe-Petersen | 155 | 330 | 22 | 85 | 29 | 564 | |
| Else Helene Ibfelt | 86 | 232 | 98 | 80 | 33 | 633 | |
| J. Schmucker-Von Koch | 175 | 377 | 42 | 107 | 10 | 600 | |
| George K. Tokuhata | 124 | 163 | 57 | 82 | 26 | 631 | |
| Luis Báez | 125 | 332 | 18 | 129 | 21 | 631 | |
| Julie Meyer | 97 | 224 | 41 | 74 | 10 | 503 | |
| Laura Venditti | 142 | 331 | 79 | 57 | 8 | 638 |
All Works
Loading papers...